{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:06:37Z","timestamp":1790629597302,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.yexcr.2018.03.014","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T15:17:34Z","timestamp":1521386254000},"page":"161-171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway"],"prefix":"10.1016","volume":"366","author":[{"given":"Lin","family":"Bai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2018.03.014_bib1","doi-asserted-by":"crossref","first-page":"17134","DOI":"10.4238\/2015.December.16.13","article-title":"Downregulation of MACC1 expression enhances cisplatin sensitivity in SKOV-3\/DDP cells","volume":"14","author":"Chen","year":"2015","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.yexcr.2018.03.014_bib2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/IGC.0000000000000282","article-title":"Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors)","volume":"24","author":"Harter","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"13 Supplement","key":"10.1016\/j.yexcr.2018.03.014_bib3","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1158\/1538-7445.AM2017-2594","article-title":"Abstract 2594: optimizing the replication of cancer genomics workflows: case studies","volume":"77","author":"Fowler","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2018.03.014_bib4","first-page":"1510","article-title":"MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy","volume":"7","author":"Chen","year":"2015","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.yexcr.2018.03.014_bib5","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.yexcr.2018.03.014_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.yexcr.2018.03.014_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2014.03.013","article-title":"Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches","volume":"347","author":"Wu","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2018.03.014_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrc706","article-title":"Multidrug resistance in cancer: role of ATP-dependent transporters","volume":"2","author":"Gottesman","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.yexcr.2018.03.014_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2119\/molmed.2014.00059","article-title":"Lapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function","volume":"20","author":"Ma","year":"2014","journal-title":"Mol. Med."},{"key":"10.1016\/j.yexcr.2018.03.014_bib10","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s12885-016-2640-3","article-title":"Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation","volume":"16","author":"Li","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2018.03.014_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrg2521","article-title":"Long non-coding RNAs: insights into functions","volume":"10","author":"Mercer","year":"2009","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.yexcr.2018.03.014_bib12","first-page":"345605","article-title":"An integrated analysis of miRNA, lncRNA, and mRNA expression profiles","volume":"2014","author":"Guo","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.yexcr.2018.03.014_bib13","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbagrm.2015.06.003","article-title":"Long noncoding RNAs: re-writing dogmas of RNA processing and stability","volume":"1859","author":"Wilusz","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.yexcr.2018.03.014_bib14","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.2174\/0929867321666140414101939","article-title":"Mechanism of cancer drug resistance and the involvement of noncoding RNAs","volume":"21","author":"Xia","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.yexcr.2018.03.014_bib15","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s13277-015-3998-6","article-title":"Overexpression of long non-coding RNA HOTAIR leads to chemoresistance by activating the Wnt\/beta-catenin pathway in human ovarian cancer","volume":"37","author":"Li","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.yexcr.2018.03.014_bib16","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1038\/sj.onc.1206928","article-title":"MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer","volume":"22","author":"Ji","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2018.03.014_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.canlet.2013.06.013","article-title":"Long non-coding RNAs: a new frontier in the study of human diseases","volume":"339","author":"Shi","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2018.03.014_bib18","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.3892\/ol.2016.4435","article-title":"Inhibition of the long non-coding RNA MALAT1 suppresses tumorigenicity and induces apoptosis in the human ovarian cancer SKOV3 cell line","volume":"11","author":"Liu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2018.03.014_bib19","doi-asserted-by":"crossref","first-page":"e0155250","DOI":"10.1371\/journal.pone.0155250","article-title":"The long noncoding RNA MALAT-1 is highly expressed in ovarian cancer and induces cell growth and migration","volume":"11","author":"Zhou","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.yexcr.2018.03.014_bib20","doi-asserted-by":"crossref","first-page":"865","DOI":"10.4149\/neo_2016_605","article-title":"Long non-coding RNA MALAT1 is up-regulated in ovarian cancer tissue and promotes SK-OV-3 cell proliferation and invasion","volume":"63","author":"Zou","year":"2016","journal-title":"Neoplasma"},{"key":"10.1016\/j.yexcr.2018.03.014_bib21","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1182\/blood-2005-08-3329","article-title":"Recent insights into the role of Notch signaling in tumorigenesis","volume":"107","author":"Leong","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2018.03.014_bib22","doi-asserted-by":"crossref","first-page":"8215","DOI":"10.18632\/oncotarget.14152","article-title":"Inhibition of gamma-secretase in Notch1 signaling pathway as a novel treatment for ovarian cancer","volume":"8","author":"Feng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2018.03.014_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/978-1-4614-0899-4_15","article-title":"Notch, apoptosis and cancer","volume":"727","author":"Dang","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.yexcr.2018.03.014_bib24","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/978-1-4614-0899-4_14","article-title":"Notch signaling pathway and cancer metastasis","volume":"727","author":"Hu","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.yexcr.2018.03.014_bib25","doi-asserted-by":"crossref","first-page":"12369","DOI":"10.1007\/s13277-014-2551-3","article-title":"MicroRNA-449a reduces cell survival and enhances cisplatin-induced cytotoxicity via downregulation of NOTCH1 in ovarian cancer cells","volume":"35","author":"Zhou","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.yexcr.2018.03.014_bib26","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1126\/science.1192002","article-title":"Long noncoding RNA as modular scaffold of histone modification complexes","volume":"329","author":"Tsai","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2018.03.014_bib27","doi-asserted-by":"crossref","first-page":"10207","DOI":"10.18632\/oncotarget.3504","article-title":"Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma","volume":"6","author":"Chen","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2018.03.014_bib28","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ygyno.2013.05.029","article-title":"Current standards of care for chemotherapy of optimally cytoreduced advanced epithelial ovarian cancer","volume":"131","author":"Markman","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.yexcr.2018.03.014_bib29","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drup.2015.11.003","article-title":"Mechanisms of cisplatin resistance and targeting of cancer stem cells: adding glycosylation to the equation","volume":"24","author":"Ferreira","year":"2016","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.yexcr.2018.03.014_bib30","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.3892\/mmr.2015.3562","article-title":"HOTAIR is a potential target for the treatment of cisplatinresistant ovarian cancer","volume":"12","author":"Wang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.yexcr.2018.03.014_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00280-017-3238-4","article-title":"Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer","volume":"79","author":"Zhang","year":"2017","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.yexcr.2018.03.014_bib32","first-page":"20565","article-title":"Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.yexcr.2018.03.014_bib33","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1159\/000478917","article-title":"Long non-coding RNA MALAT1 decreases the sensitivity of resistant glioblastoma cell lines to temozolomide","volume":"42","author":"Li","year":"2017","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.yexcr.2018.03.014_bib34","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1097\/JTO.0b013e3182307eac","article-title":"The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth","volume":"6","author":"Schmidt","year":"2011","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.yexcr.2018.03.014_bib35","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/0008-5472.CAN-12-2850","article-title":"The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells","volume":"73","author":"Gutschner","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2018.03.014_bib36","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.3892\/etm.2017.4304","article-title":"Long non-coding RNA MALAT1 is upregulated and involved in cell proliferation, migration and apoptosis in ovarian cancer","volume":"13","author":"Wu","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.yexcr.2018.03.014_bib37","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1158\/1535-7163.MCT-16-0591","article-title":"MALAT1 is associated with poor response to oxaliplatin-based chemotherapy in colorectal cancer patients and promotes chemoresistance through EZH2","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.yexcr.2018.03.014_bib38","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.bbrc.2016.08.065","article-title":"The HIF-2alpha-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2018.03.014_bib39","doi-asserted-by":"crossref","first-page":"e2515","DOI":"10.1038\/cddis.2016.408","article-title":"Inflammation and Notch signaling: a crosstalk with opposite effects on tumorigenesis","volume":"7","author":"Fazio","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2018.03.014_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.canlet.2008.09.030","article-title":"Emerging role of Notch in stem cells and cancer","volume":"279","author":"Wang","year":"2009","journal-title":"Cancer Lett."},{"key":"10.1016\/j.yexcr.2018.03.014_bib41","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.3892\/or.2015.4320","article-title":"Caveolin-1 mediates chemoresistance in cisplatin-resistant ovarian cancer cells by targeting apoptosis through the Notch-1\/Akt\/NF-kappaB pathway","volume":"34","author":"Zou","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.yexcr.2018.03.014_bib42","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1186\/s12885-015-1625-y","article-title":"Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy","volume":"15","author":"Kim","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/j.yexcr.2018.03.014_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.apjtm.2017.01.005","article-title":"Targeted inhibition of Notch1 gene enhances the killing effects of paclitaxel on triple negative breast cancer cells","volume":"10","author":"Zhou","year":"2017","journal-title":"Asian Pac. J. Trop. Med."},{"key":"10.1016\/j.yexcr.2018.03.014_bib44","first-page":"879","article-title":"Silencing Notch-1 induces apoptosis and increases the chemosensitivity of prostate cancer cells to docetaxel through Bcl-2 and Bax","volume":"3","author":"Ye","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.yexcr.2018.03.014_bib45","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/CAD.0000000000000227","article-title":"Notch 1 promotes cisplatin-resistant gastric cancer formation by upregulating lncRNA AK022798 expression","volume":"26","author":"Hang","year":"2015","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.yexcr.2018.03.014_bib46","doi-asserted-by":"crossref","first-page":"38227","DOI":"10.18632\/oncotarget.9611","article-title":"Long noncoding RNA ZFAS1 promotes gastric cancer cells proliferation by epigenetically repressing KLF2 and NKD2 expression","volume":"8","author":"Nie","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.yexcr.2018.03.014_bib47","doi-asserted-by":"crossref","first-page":"20778","DOI":"10.1073\/pnas.1019452108","article-title":"Notch1 regulates the expression of the multidrug resistance gene ABCC1\/MRP1 in cultured cancer cells","volume":"108","author":"Cho","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.yexcr.2018.03.014_bib48","first-page":"2143","article-title":"Metastasis-associated lung adenocarcinoma transcript 1 promotes the proliferation of chondrosarcoma cell via activating Notch-1 signaling pathway","volume":"9","author":"Xu","year":"2016","journal-title":"Onco Targets Ther."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718301447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482718301447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T08:27:47Z","timestamp":1660638467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482718301447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0014482718301447"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.03.014","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knockdown of MALAT1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2018.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}